Urinary Metabolites Diagnostic and Prognostic of Intrahepatic Cholangiocarcinoma

BACKGROUND: Liver cancer is the second leading cause of cancer-related deaths worldwide. With a predicted 2.4-fold rise in liver cancer incidence by 2020, there is an urgent need for early, inexpensive diagnostic biomarkers to deploy in the clinic. METHODS: We employed ultra-performance liquid chrom...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Epidemiol Biomarkers Prev
Main Authors: Haznadar, Majda, Diehl, Christopher M., Parker, Amelia L., Krausz, Kristopher W., Bowman, Elise D., Rabibhadana, Siritida, Forgues, Marshonna, Bhudhisawasdi, Vajarabhongsa, Gonzalez, Frank J., Mahidol, Chulabhorn, Budhu, Anuradha, Wang, Xin W., Ruchirawat, Mathuros, Harris, Curtis C.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6774833/
https://ncbi.nlm.nih.gov/pubmed/31358519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-19-0453
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados